Covid-19 roundup: Tillman Gerngross inks deal to bring antibody candidate to India; At FDA's request, mRNA vaccine makers will expand trials for children ages 5-11
A week after it was reported that India’s Covid-19 death toll could be in the millions, antibody legend Tillman Gerngross has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
